Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670728 | SCV000795621 | uncertain significance | Sandhoff disease | 2017-11-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000670728 | SCV001403052 | likely pathogenic | Sandhoff disease | 2023-09-12 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 150 of the HEXB protein (p.Thr150Pro). This variant is present in population databases (no rsID available, gnomAD no frequency). This missense change has been observed in individual(s) with Sandhoff disease (PMID: 22848519, 23046579). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 554994). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Natera, |
RCV000670728 | SCV002084938 | likely pathogenic | Sandhoff disease | 2020-10-30 | no assertion criteria provided | clinical testing |